{"prompt": "['APPENDIX 11: SERIOUS ADVERSE EVENT REPORT FORM', 'PRODIGE 59 - FFCD 1707 - DURIGAST', 'T', 'M', 'Page 1/3', 'SERIOUS ADVERSE EVENT REPORT FORM (SAE)', 'CRA Initials', 'SPONSOR : FFCD', 'PRINCIPAL INVESTIGATOR : Pr David TOUGERON', 'Study title : A randomized phase Il study evaluating FOLFIRI + durvalumab vs FOLFIRI + durvalumab and tremelimumab in second-line', 'treatment of patients with advanced gastric or gastro-oesophageal junction adenocarcinoma. Randomized - non-comparative -', 'multicenter phase Il', 'N\u00b0 EudraCT : 2018-002014-13', 'Author of the declaration : Dr', 'Pr', 'CRA', 'Other', 'specify :', 'Name :', 'Center :', 'Phone :', 'Fax :', 'SAE n\u00b0 :', 'Type of report :', 'initial', 'follow-up n\u00b0 :', 'Date of report :', 'SPACE RESERVED FOR DATA CENTER (CRGA)', 'Date of reception :', 'Sponsor reference for the event', ':', 'FOLFIRI + durvalumab', 'Patient N\u00b0', \"Patient's initials :\", 'Sex :', 'Female', 'Male', 'FOLFIRI + durvalumab +', 'tremelimumab (irinot\u00e9can 150', 'Inclusion date :', 'mg/m\u00b2)', 'Date of birth :', 'FOLFIRI + durvalumab +', 'tremelimumab', '(irinot\u00e9can 180 mg/m\u00b2)', 'Weight (kg) :', 'Height (cm) :', 'Serious adverse event :', 'Date of start :', 'Date of end :', 'Seriousness criteria', 'Grade/severity', 'Outcome', 'hospitalization (or prolongation)', 'Coded as NCI-CTC 4.0', 'recovered/resolved without', 'medically significant', 'If not applicable, specify :', 'durable or significant disability or incapacity', 'sequelae', '1 = mild', 'recovered/resolved', 'with', 'life-threatening', '2 = moderate', 'death', 'sequelae', '3 = severe', 'recovering/resolving', 'congenital anomaly or fetal malformation', '4 = life-threatening', 'not recovered/resolved', '5 = death due to SAE', 'death', 'If hospitalization', 'Date of admission', ':', 'ongoing', 'Date of discharge', ':', 'If death', 'Date of death', ':', 'Death cause', 'Specify :', 'Death related to SAE', 'Death for which SAE may have contributed', 'Death related to SAE', 'Description', 'Please describe below the chronological sequence of events including the history of the disease and the relevant concomitant', 'diseases existing in the context of the Serious Adverse Event.', 'PRODIGE 59 - DURIGAST -', 'Version 2.0 - 04.08.2020 ENG', 'Page 114 de 123']['PRODIGE 59 - FFCD 1707 - DURIGAST', 'Page 2/3', 'SAE n\u00b0:', 'T', 'M', 'initial', 'follow-up', 'SERIOUS ADVERSE EVENT REPORT FORM (SAE)', 'CRA Initials', 'Patient N\u00b0', ':', 'Drug', 'Administration', 'Last dose', 'Treatment modification due to SAE', 'If arm B, specify treatment sequence when SAE occurs :', 'FOLFIRI + durvalumab + tremelimumab', 'FOLFIRI + durvalumab', 'Date of first administration :', 'Dose not changed', 'I', 'Irinotecan', 'Dose reduced, specify : new dose :', 'mg', 'Date of last administration before', 'Temporary withdrawal, specify date of reintroduction :', 'Not', 'SAE :', 'mg', 'I', 'I', 'applicable', 'Definitive withdrawal, specify date :', 'Cycle n\u00b0:', 'Date of first administration :', 'Dose not changed', 'I', 'Folinic acid', 'Dose reduced, specify : new dose :', 'mg', 'Date of last administration before', 'D-L', 'L', 'Temporary withdrawal, specify date of reintroduction', ':', 'Not', 'SAE :', 'mg', 'applicable', 'Definitive withdrawal, specify date :', 'Cycle n\u00b0:', 'Date of first administration :', 'Dose not changed', '5-FU bolus', 'Dose reduced, specify : new dose :', 'mg', 'Date of last administration before', 'Temporary withdrawal, specify date of reintroduction', ':', 'Not', 'SAE :', 'mg', 'applicable', 'Definitive withdrawal, specify date :', 'Cycle n\u00b0:', 'Date of first administration :', 'Dose not changed', '5-FU infusion', 'Dose reduced, specify : new dose :', 'mg', 'Date of last administration before', 'Temporary withdrawal, specify date of reintroduction', ':', 'Not', 'SAE :', 'mg', 'applicable', 'Definitive withdrawal, specify date :', 'Cycle n\u00b0', 'Date of first administration', ':', 'Dose not changed', 'Durvalumab', 'Dose reduced, specify : new dose :', 'mg', 'Date of last administration before', 'Temporary withdrawal, specify date of reintroduction', ':', 'Not', 'SAE :', 'mg', 'applicable', 'Definitive withdrawal, specify date :', 'Cycle n\u00b0:', 'PRODIGE 59 - DURIGAST -', 'Version 2.0 - 04.08.2020 ENG', 'Page 115 de 123']\n\n###\n\n", "completion": "END"}